These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22283898)

  • 61. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.
    Toczek A; Cox H; du Cros P; Cooke G; Ford N
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):299-307. PubMed ID: 23211716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
    Jeena L; Naidoo K
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):235-9. PubMed ID: 26792477
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome.
    Keshavjee S; Gelmanova IY; Shin SS; Mishustin SP; Andreev YG; Atwood S; Furin JJ; Miller A
    Int J Tuberc Lung Dis; 2012 May; 16(5):596-603. PubMed ID: 22410436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.
    Gelmanova IY; Keshavjee S; Golubchikova VT; Berezina VI; Strelis AK; Yanova GV; Atwood S; Murray M
    Bull World Health Organ; 2007 Sep; 85(9):703-11. PubMed ID: 18026627
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study.
    Mukasa J; Kayongo E; Kawooya I; Lukoye D; Etwom A; Mugabe F; Tweya H; Izizinga R; Mijumbi-Deve R
    Afr Health Sci; 2020 Jun; 20(2):625-632. PubMed ID: 33163023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.
    Jenkins HE; Ciobanu A; Plesca V; Crudu V; Galusca I; Soltan V; Cohen T
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):373-80. PubMed ID: 23407226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thai health education program for improving TB migrant's compliance.
    Khortwong P; Kaewkungwal J
    J Med Assoc Thai; 2013 Mar; 96(3):365-73. PubMed ID: 23539943
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tuberculosis treatment default in a large tertiary care hospital in urban Nigeria: prevalence, trend, timing and predictors.
    Ifebunandu NA; Ukwaja KN
    J Infect Public Health; 2012 Oct; 5(5):340-5. PubMed ID: 23164562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk factors for treatment default among adult tuberculosis patients in Indonesia.
    Rutherford ME; Hill PC; Maharani W; Sampurno H; Ruslami R
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1304-9. PubMed ID: 24025382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tuberculosis treatment default at the communicable diseases unit of Effia-Nkwanta Regional Hospital: a 2-year experience.
    Dodor EA
    Int J Tuberc Lung Dis; 2004 Nov; 8(11):1337-41. PubMed ID: 15581202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India.
    Negandhi H; Tiwari R; Sharma A; Nair R; Zodpey S; Reddy Allam R; Oruganti G
    Glob Health Action; 2017; 10(1):1290315. PubMed ID: 28485693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of pharmacist-led patient education on adherence to tuberculosis treatment.
    Clark PM; Karagoz T; Apikoglu-Rabus S; Izzettin FV
    Am J Health Syst Pharm; 2007 Mar; 64(5):497-505. PubMed ID: 17322163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surveillance of tuberculosis treatment outcomes of Singapore citizens and permanent residents, 2002-2011.
    Chee CB; Lim LK; KhinMar KW; Han KY; Gan SH; Cutter J; Ooi PL; Wang YT
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):141-6. PubMed ID: 24429304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of lay health workers' needs to effectively support anti-tuberculosis treatment adherence in Malawi.
    Puchalski Ritchie LM; van Lettow M; Barnsley J; Chan AK; Joshua M; Martiniuk AL; Schull MJ; Zwarenstein M
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1492-7. PubMed ID: 22964096
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of an innovative tuberculosis financing and payment model on health service utilization by tuberculosis patients in China: do the poor fare better than the rich?
    Dong D; Jiang WX; Long Q; Huang F; Zhang H; Chen JY; Xiang L; Li Q; Tang SL; Lucas H
    Infect Dis Poverty; 2019 Jun; 8(1):44. PubMed ID: 31182164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favela.
    Soares EC; Vollmer WM; Cavalcante SC; Pacheco AG; Saraceni V; Silva JS; Neves GR; Golub JE; Efron AR; Durovni B; Chaisson RE
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1581-6. PubMed ID: 24200272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors affecting defaulting from DOTS therapy under the national programme of tuberculosis control in Alexandria, Egypt.
    El-Din MN; Elhoseeny T; Mohsen AM
    East Mediterr Health J; 2013 Feb; 19(2):107-13. PubMed ID: 23516818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MDR tuberculosis and non-compliance with therapy.
    Ereqat S; Spigelman M; Bar-Gal GK; Ramlawi A; Abdeen Z
    Lancet Infect Dis; 2011 Sep; 11(9):662. PubMed ID: 21867955
    [No Abstract]   [Full Text] [Related]  

  • 79. Status of re-registered patients for tuberculosis treatment under DOTS programme.
    Chandrasekaran V; Gopi PG; Santha T; Subramani R; Narayanan PR
    Indian J Tuberc; 2007 Jan; 54(1):12-6. PubMed ID: 17455418
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of community participation on treatment outcomes and compliance of DOTS patients in Iraq.
    Niazi AD; Al-Delaimi AM
    East Mediterr Health J; 2003 Jul; 9(4):709-17. PubMed ID: 15748068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.